Regulation of CCL18 by Corticosteroids in Severe Asthma
NCT03779152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2018-12-21
Summary
The majority of asthmatic patients are well controlled by inhaled corticosteroid treatment, however some severe asthma resist this treatment. CCL18 is a target gene for corticosteroids and its dysfunction may correlate with phenotypes of asthma.
Conditions
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Benoit Wallaert, MD, PhD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- France
Study Locations
More Related Trials
-
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162 ·Status: COMPLETED
-
Develop and Implement Asthma Controlling Strategies (1)
NCT00005732 ·Status: COMPLETED
-
Longitudinal Observational Study of Severe Asthma
NCT01780142 ·Status: COMPLETED
-
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
NCT01078688 ·Status: COMPLETED
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
NCT01577082 ·Status: COMPLETED ·Phase: PHASE3
-
Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years)
NCT03960359 ·Status: ACTIVE_NOT_RECRUITING
-
The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
NCT01741805 ·Status: WITHDRAWN
-
Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission
NCT00526019 ·Status: COMPLETED
-
Develop and Implement Asthma Controlling Strategies (2)
NCT00005733 ·Status: COMPLETED
-
Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
NCT03128762 ·Status: COMPLETED
-
Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
NCT03784781 ·Status: WITHDRAWN
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
Risk Factors Associated to Difficult-to-control Asthma
NCT01089322 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
NCT00189722 ·Status: COMPLETED ·Phase: PHASE2
-
Asthma Origins and Remission Study
NCT03141814 ·Status: UNKNOWN
-
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
NCT00189787 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Treatable Traits of Severe Asthma
NCT06811740 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training
NCT04395937 ·Status: RECRUITING ·Phase: NA
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations
NCT01460862 ·Status: WITHDRAWN
-
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
NCT00133042 ·Status: COMPLETED ·Phase: PHASE4
-
Family Process, Adherence, and Child Asthma Outcome
NCT00005390 ·Status: COMPLETED